Skip to main content
Fig. 8 | Cancer Cell International

Fig. 8

From: CD5L-associated gene analyses highlight the dysregulations, prognostic effects, immune associations, and drug-sensitivity predicative potentials of LCAT and CDC20 in hepatocellular carcinoma

Fig. 8

The dysregulations, diagnostic power and correlations of CD5L, LCAT and CDC20 in HCC. A Lower CD5L in HCC tumors than their paired controls at protein level. B Lower LCAT in HCC tumors than their paired controls at protein level. C Higher CD5L expression in HCC tumors than their paired controls at protein level. D–F ROC analyses of CD5L, LCAT and CDC20 in discriminating HCC tumors and normal liver controls. G–I Spearman correlation analyses of CD5L, LCAT and CDC20 expressions in HCC at protein level. ROC, receiver operating characteristic. Two-sided paired Wilcoxon test, ROC analysis and Spearman analysis were used and p < 0.05 was considered significant

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us